Pharmala Biotech Holdings Probability of Future Pink Sheet Price Finishing Under 0.25
| PMBHFDelisted Stock | 0.25 0.00 0.00% |
Pharmala |
Pharmala Biotech Target Price Odds to finish below 0.25
The tendency of Pharmala Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 0.25 | 90 days | 0.25 | about 41.73 |
Based on a normal probability distribution, the odds of Pharmala Biotech to move below current price in 90 days from now is about 41.73 (This Pharmala Biotech Holdings probability density function shows the probability of Pharmala Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Pharmala Biotech has a beta of 0.16 indicating as returns on the market go up, Pharmala Biotech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Pharmala Biotech Holdings will be expected to be much smaller as well. Additionally Pharmala Biotech Holdings has an alpha of 0.2633, implying that it can generate a 0.26 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Pharmala Biotech Price Density |
| Price |
Predictive Modules for Pharmala Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharmala Biotech Holdings. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Please note, it is not enough to conduct a financial or market analysis of a single entity such as Pharmala Biotech. Your research has to be compared to or analyzed against Pharmala Biotech's peers to derive any actionable benefits. When done correctly, Pharmala Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Pharmala Biotech Holdings.Pharmala Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pharmala Biotech is not an exception. The market had few large corrections towards the Pharmala Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pharmala Biotech Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pharmala Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.26 | |
β | Beta against Dow Jones | 0.16 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | 0.01 |
Pharmala Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pharmala Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pharmala Biotech Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pharmala Biotech is not yet fully synchronised with the market data | |
| Pharmala Biotech has some characteristics of a very speculative penny stock |
Pharmala Biotech Technical Analysis
Pharmala Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Pharmala Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pharmala Biotech Holdings. In general, you should focus on analyzing Pharmala Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Pharmala Biotech Predictive Forecast Models
Pharmala Biotech's time-series forecasting models is one of many Pharmala Biotech's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pharmala Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Pharmala Biotech Holdings
Checking the ongoing alerts about Pharmala Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pharmala Biotech Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Pharmala Biotech is not yet fully synchronised with the market data | |
| Pharmala Biotech has some characteristics of a very speculative penny stock |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Pharmala Pink Sheet
If you are still planning to invest in Pharmala Biotech Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pharmala Biotech's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |